“Elucidating the Potential Compounds Targeting OPNL1W Through Virtual Screening for the Treatment of Color Blindness”, Mol. Med. Com., vol. 4, no. 01, pp. 31–42, Jun. 2024, doi: 10.55627/mmc.004.001.0462.